Description
COMPOSITION: Each tablet contains Sofosbuvir 400 + Ledipasvir 90 mg
INDICATION: LEDIKAST is a fixed dose combination of hepatitis C virus nucleotide analog NSSB polymerase
inhibitor and NSSA inhibitor indicated for the treatment of:
- Indicated for the treatment of chronic HCV genotype 1 in adults
PACKING: 28 Tablets / Bottle